Ephedra Ruling Does Not Preclude FDA Legal Action In New District – Lawyers
This article was originally published in The Tan Sheet
Executive Summary
The recent court ruling overturning FDA's ephedra ban is unlikely to extend to higher-dose forms, according to food and drug law experts
You may also be interested in...
FDA Must Recognize Ephedra Ruling’s Nationwide Implications – Emord
A Utah court ruling lifting an FDA ban on low-dose ephedra applies nationwide and cannot be interpreted by the agency as pertaining only to the district where the decision was issued, according to Jonathan Emord of the Washington, D.C. law firm Emord & Associates
FDA Must Recognize Ephedra Ruling’s Nationwide Implications – Emord
A Utah court ruling lifting an FDA ban on low-dose ephedra applies nationwide and cannot be interpreted by the agency as pertaining only to the district where the decision was issued, according to Jonathan Emord of the Washington, D.C. law firm Emord & Associates
FDA Must Recognize Ephedra Ruling’s Nationwide Implications – Emord
A Utah court ruling lifting an FDA ban on low-dose ephedra applies nationwide and cannot be interpreted by the agency as pertaining only to the district where the decision was issued, according to Jonathan Emord of the Washington, D.C. law firm Emord & Associates